Am J Transplant, Volume 19, Suppl 3 Archives - Page 113 of 214 - ATC Abstracts

2019 American Transplant Congress
Reevaluating Cut-Off Points for the Expansion of Deceased Donor Criteria for Kidney Transplantation in Japan
Y. NAKAGAWA¹, M. Masahiro², M. Tasaki², K. Saito³, K. Takahashi⁴
¹Department of Urology,, Uonuma Kikan Hospital, Niigata, Japan, ²Department of Regenerative and Transplant Medicine, Niigata University, Niigata, Japan, ³Department of Urology,, Niigata University, Niigata, Japan, ⁴Department of Urology,, Otsukadai Clinic, Tokyo, Japan
*Purpose: A shortage of donors poses a serious problem for organ transplantation around the world. In response, the concept of the Expanded Criteria Donor (ECD)…
2019 American Transplant Congress
The Effect Of Tacrolimus Trough Variability On Kidney Transplant Outcomes
S. Heeney¹, K. R. Szempruch¹, R. Lee¹, A. Mintz², P. Serrano¹, R. Detwiler¹, C. Doligalski¹
¹University of North Carolina Medical Center, Chapel Hill, NC, ²University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC
*Purpose: High variability in tacrolimus as assessed by tacrolimus coefficient of variability (TCV) in trough levels of kidney transplant recipients (KTRs) has been associated with…
2019 American Transplant Congress
Belatacept Conversion for Calcineurin Inhibitor-Associated Thrombotic Microangiopathy in Kidney Transplant Recipients
S. A. Muhsin, K. Safa, H. M. Gilligan, E. C. Heher, W. W. Williams, D. M. Wojciechowski
Nephrology Division, MGH, Boston, MA
*Purpose: Thrombotic Microangiopathy (TMA) in kidney transplant recipients is a serious complication that can cause graft loss. It can be associated with immunosuppressive medications such…
2019 American Transplant Congress
Chloroquine’s Effect on T cell Proliferation
R. Muschalek¹, P. Jindra², R. Kerman², M. Kueht², W. Etheridge², M. Cusick²
¹Baylor College of Medicine, Houston, TX, ²Department of Surgery, Baylor College of Medicine, Houston, TX
*Purpose: An anti-malarial agent, Chloroquine (CQ), has been widely used for the treatment of rheumatoid arthritis and lupus. Although the precise mechanisms of CQ are…
2019 American Transplant Congress
Renal Safety Of Entecavir And Tenofovir With Hepatitis B Immunoglobulin In Liver Transplant Patients
D. Kim¹, J. Lee¹, E. Kim¹, S. Kim¹, K. Ihn¹, D. Joo¹, K. Huh¹, B. Kim², M. Kim¹, S. Kim¹, Y. Kim¹, J. Lee¹
¹Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of, ²Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
*Purpose: Combination of potent nucleos(t)ide analougues (NAs) and hepatitis B immunoglobulin is recommended after liver transplantation for the prevention of hepatitis B virus (HBV) recurrence.…
2019 American Transplant Congress
The Effect of Lifestyle Intervention on Physical Functionality, Progress of Liver Disease and Mortality in Decompensated Cirrhosis Patients in a Community Model
S. Habib, F. Alsafar
Liver Institute PLLC, Tucson, AZ
*Purpose: The study was designed to look at relationships between diet and exercise interventions and liver disease prognosis in terms of survival and ability to…
2019 American Transplant Congress
Dobutamine Stress Echocardiography is a Poor Predictor of Clinically Significant Coronary Artery Disease in Patients Undergoing Liver Transplant Evaluation
D. L. Hughes¹, J. Rice¹, J. R. Burton¹, E. A. Pomfret², J. J. Pomposelli², A. V. Ambardekar³, S. M. Mandell⁴, M. S. Kriss¹
¹Division of Gastroenterology & Hepatology, University of Colorado School of Medicine (UCSOM), Aurora, CO, ²Division of Transplant Surgery, UCSOM, Aurora, CO, ³Division of Cardiology, UCSOM, Aurora, CO, ⁴Department of Anesthesiology, UCSOM, Aurora, CO
*Purpose: Given the high incidence of major cardiac events in the first year post-liver transplantation (LT) (>30%), the aim of this study was to determine…
2019 American Transplant Congress
Transmission of Infections from Organ Donor to Recipient – German Data
K. Moench, A. Rahmel, A. P. Barreiros
German Foundation for Organtransplantation (DSO), Frankfurt, Germany
*Purpose: In Europe, vigilance monitoring after organ transplant includes Serious Adverse Events (SAE) as well as Serious Adverse Reactions (SAR). All SAE and SAR related…
2019 American Transplant Congress
Respiratory Viral Infections and Patient Outcomes in Solid Organ Transplant Recipients
M. Gonzalez¹, A. Vostal¹, N. Darling², C. Papastamelos², M. Natarajan³, P. Kumar³, J. Timpone³
¹Internal Medicine, MedStar Georgetown University Medical Center, Washington, DC, ²School of Medicine, Georgetown University, Washington, DC, ³Infectious Disease, MedStar Georgetown University Medical Center, Washington, DC
*Purpose: Community acquired respiratory viral infections (RVI) have been associated with significant morbidity and mortality in solid organ transplant recipients (SOTR). Acute rejection and allograft…
2019 American Transplant Congress
Donor Derived Cell Free DNA (dd-cfDNA) May Aid in the Diagnosis of BK Virus Nephropathy
D. Brennan¹, J. Bromberg², J. Yee³, S. Dholakia³, M. Haas⁴
¹Johns Hopkins, Baltimore, MD, ²University of Maryland School of Medicine, Baltimore, MD, ³CareDx, Brisbane, CA, ⁴Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Between 10% and 30% of renal transplant recipients (KTR) develop BK viremia; with 1-10% of KTR developing BK virus associated nephropathy (BKVAN), accounting for…